PO-0241 EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer. (May 2021) - Robin, S.; Chabaud, S.; Serre, A.; Bringeon, B.; Clippe, S.; Rocher, F.; Desmettre, O.; Bringeon, G.; Gassa, F.; Pommier, P.